Ticker League

Edwards Lifesciences (EW) Free Cash Flow Bridge

Pinpoint what moved Edwards Lifesciences's FCF from TTM through Q1 2025 to TTM through Q1 2026 — operating cash flow shifts and capex changes, each driver sized in dollars.

TTM

FCF YoY

+66.82%

OCF YoY

+55.06%

Capex YoY

+20.62%

FCF Conversion Δ

+5.7 pp

Free cash flow bridge for Edwards Lifesciences (EW) — TTM through Q1 2026 vs TTM through Q1 2025

Δ Free cash flow: $436M

FCF bridge breakdown for Edwards Lifesciences (EW) — TTM through Q1 2026 vs TTM through Q1 2025

  • Prior Free Cash Flow$653M
  • Operating Cash Flow$482M
  • Capital Expenditure-$46M
  • Free Cash Flow$1.09B
Identity check: drivers reconcile to ΔNI within $0.00
Want to see how cash flow is built up?Cash Flow Waterfall

Frequently asked questions

Data & methodology

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation